New tools to bridge the gap between the lab and patients in our update from day 2 of the 2019 HD Therapeutics conference
Critical Path Institute launches new initiative to get HD drugs licensed as quickly as possible
A potential HD biomarker has been uncovered in a recent clinical study
HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta - day 2
Strategies for getting rid of mutant huntingtin & clinical trial updates: day 2 of the HD therapeutics conference
Sleep deficits precede motor problems in HD
HD brain fluid makes brain cells grow clumps.
How will we know whether HD-lowering treatments are working? New advancements in the detection of mutant huntingtin.
A new biomarker reveals brain changes in early Huntington's disease.